Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh

Vaccine

Volumn 31, Issue 51, 2013, Pages 6058-6064

  Khan, Iqbal Ansary ^a   Saha, Amit ^a   Chowdhury, Fahima ^a   Khan, Ashraful Islam ^a   Uddin, Md Jasim ^a   Begum, Yasmin A ^a   Riaz, Baizid Khoorshid ^b   Islam, Sanjida ^b   Ali, Mohammad ^c   Luby, Stephen P ^d   Clemens, John D ^a   Cravioto, Alejandro ^c   Qadri, Firdausi ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b Government of the Peoples Republic of Bangladesh   (Bangladesh)

^c International Vaccine Institute   (South Korea)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Bangladesh; Cholera vaccine; Complete dose; Endemic high risk targeted population; Feasibility

Indexed keywords

CHOLERA VACCINE; SHANCHOL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; AWARENESS; BANGLADESH; CHILD; CHOLERA; COMMON COLD; COUGHING; DIARRHEA; FEMALE; FEVER; GASTRITIS; HAND WASHING; HEALTH CARE COST; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MASS IMMUNIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URBAN POPULATION; VOMITING; WATER QUALITY;

BANGLADESH; CHOLERA VACCINE; COMPLETE DOSE; ENDEMIC HIGH RISK TARGETED POPULATION; FEASIBILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BANGLADESH; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; REFRIGERATION; URBAN POPULATION; VACCINATION; YOUNG ADULT;

EID: 84888434371     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.021     Document Type: Article

References (23)

1. Cavailler P., Lucas M., Perroud V., McChesney M., Ampuero S., Guerin P.J., et al. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 2006, 24:4890-4895.
2. Vu D.T., Hossain M.M., Son N.D., Hoa N.T., Rao M.R., Canh D.G., et al. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr 2003, 21(December (4)):304-308.
3. Legros D., Paquet C., Marty W.P.I., Kenya Mugisha N., Royer H., Neira M., et al. Mass vaccination with two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 1999, 77(10).
4. Clemens J.D., Sack D., Harris J., Chakraborty J., Khan M.R., Stanton B., et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, 2:124.
5. WHO Cholera global surveillance summary, 2008. WHO Wkly Epidemiol Rec 2009, 84(July (13)):309-324.
6. Chaignat C.L., Monti V. Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr 2007, 25:244-261.
7. Lucas M.E., Deen J.L., von Seidlein L., Wang X.Y., Ampuero J., Puri M., et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005, 352:757-767.
8. Sanchez J.L., Vasquez B., Begue R.E., Meza R., Castellares G., Cabezas C., et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 1994, 344:1273-1276.
9. Van Loon F.P., Clemens J.D., Chakraborty J., Rao M.R., Kay B.A., Sack D.A., et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 1996, 14:162-166.
10. WHO Cholera, 2010. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations [Wkly Epidemiol Rec/Health Sec Secret League Nations] 2010, 86(July (31)):325-339.
11. Sur D., Kanungo S., Sah B., Manna B., Ali M., Paisley A.M., et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized. Controlled Trial PLoS Negl Trop Dis 2011, 5(10):e1289.
12. Longini I.M., Ali M., Yunus M., Shenvi N., Clemens J.D. Controlling endemic cholera with oral vaccines. PLoS Med 2007, 4:e336.
13. Ali M., Emch M., von Seidlein L., Yunus M., Sack D.A., Rao M., et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005, 366:44-49.
14. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 - conclusions and recommendations. WHO Wkly Epidemiol Rec 2009, 84(December (50)):517-532.
15. Cholera vaccines WHO position paper. WHO Wkly Epidemiol Rec 2010, 85(March (13)):117-118.
16. Cholera, 2010. WHO Wkly Epidemiol Rec 2011, 86(July (31)):325-340.
17. Chowdhury F., Rahman M.A., Begum Y.A., Khan A.I., Faruque A.S., Saha N.C., et al. Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl Trop Dis 2011, 5(4):e999.
18. Clemens J., Shin S., Ali M. New approaches to the assessment of vaccine herd protection in trials conducted before licensure. Lancet Infect Dis 2011, 11(6):482-487.
19. Mahalanabis D., Lopez A.L., Sur D., Deen J., Manna B., Kanungo S., et al. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS ONE 2008, 3(6):e2323.
20. Saha A., Chowdhury M.I., Khanam F., Saruar Bhuiyan Md., Chowdhury F., Khan A.I., et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 2011, 29:8285-8292.
21. Paving the way f or the control of Cholera and Typhoid fever in Kolkata - A research project report of the NICED-IVI collaboration (2005-2006). Kolkata, India; 2009.
22. Ciglenecki I., Sakoba K., Luquero F.J., Heile M., Itama C., Mengel M., et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med 2013, 10(September (9)):e1001512.
23. WHO Immunization service delivery. Projected vaccine wastage, January 15 2012.